Global Laparoscopic Robotic Assisted Prostatectomy Market Size Likely to Grow at a CAGR of 9.2% By 2035

The size of the market in terms of USD of the global laparoscopic robotic assisted prostatectomy is estimated at USD 4.67 billion in the year 2026 and projected to reach USD 11.24 billion in the year 2035 and is expected to gain at an average of 9.2% per annum between the year 2026 and 2035.

Laparoscopic Robotic Assisted Prostatectomy Market Revenue and Trends

Global laparoscopic robotic assisted prostatectomy market comprises of the state of the art surgical systems, instruments, endoscopes, consumables that are used disposably and services that are related to the minimally invasive treatment of prostate cancer through robotically enhanced laparoscopic procedures, which suggests precision, less blood loss and quicker recovery. The market of laparoscopic robotic assisted prostatectomy globally is developing fast due to the growing rates of prostate cancer among the aging population, the growing use of robots in urology, the emergence of new healthcare infrastructure, the growing popularity of outpatient surgery, and the development of AI-based robotics, 3D imagery, and haptic feedback systems in the world.

What are the Factors That Have a Significant Contribution to the Growth of the laparoscopic robotic assisted prostatectomy market?

Increased demand the rapid growth in demand of accurate, minimal invasive surgical solutions has been driven by the rise in diagnosis of prostate cancer (now affecting more than 1.4 million men each year based on the global statistics on health) and the rise in survival rates as well as the preference of patients to minimal hospitalization and adverse effects. Reports in the industry indicate that robotic-assisted procedures constitute a considerable percentage of radical prostatectomsies in developed countries due to the surgeon training programs and excellent functional outcomes. With the increase in ageing population and growing awareness about screening, hospitals are in need of superior systems to increase efficiency during surgical procedures and consumer satisfaction.

There are technological advances that have been made, with AI-based navigation, single-port robotics to access less invasive, a greater integration of imaging, and a reusable modular-designed instrument, which has enhanced precision, procedure time, and cost-effectiveness. Other factors are increased attention to value-based care, enhanced reimbursement regulations on robotic surgery, and government funding in cancer care facilities in both mature and developing markets.

Segment Insight

By Product Type

As of 2025, robotic surgical systems dominated the first authoritative product with the highest share of the laparoscopic robotic assisted prostatectomy market due to the need to utilize multi-arm platforms with 3D HD visualization and tremor filtration necessitating nerve-sparing prostatectomies. Also essential to high-precision tumor resection and functional preservation these systems have experienced a strong growth with advances in compact and AI-enhanced systems that reduce the times to set up and are more ergonomic (widely considered by surgeons as a critical factor in improving outcomes and increasing accessibility in urology centers).

By Distribution Channel

Direct sales by the manufacturers have the highest market share as it forms the major channel of installing the systems, training programs, maintenance contract, and custom configurations. These avenues offer high-level surgical services, regulatory compliance, and bundled service solutions to hospitals, surgical facilities and urology departments with high volumes of cancer operations, and are therefore the choice of healthcare providers with high workflows that are predominantly specialized and technology-intensive.

Regional Insights

The global laparoscopic robotic aided prostatectomy market is dominated by North America because of the high rate of prostate cancer, high adoption of robotic surgery in major cancer centers, high investments in R and development of the product, and good reimbursement conditions. The area enjoys big innovators, high density of specialized hospitals, early adoption of next-gen robotics that leads to constant improvements and procedure volume.

Concurrently, it can be seen that the Asia Pacific region has the highest growth rate in the laparoscopic robotic assisted prostatectomy market due to the growing age rate, the escalating cancer rates, growing medical tourism to seek advanced treatment, and the growing investments in robotic infrastructure. In other countries such as China, India and Japan, the adoption of affordable robotic systems is on the increase, driven by programs of modernization of the healthcare systems of the countries, surgeon training programs and the growth of the private hospital capacity. The markets of the Asian pacific also grow further by urbanization, better diagnostics, and emphasis on minimal invasive oncology.

Report Scope

Recent Developments

• In April 2025: Intuitive Surgical launched the da Vinci 5 system with enhanced AI-driven analytics and single-port capabilities for prostatectomy, improving precision in nerve-sparing procedures and reducing operative times by up to 20%.

List of the prominent players in the Laparoscopic Robotic Assisted Prostatectomy Market:

• Intuitive Surgical Inc.

• Medtronic plc (Hugo RAS System)

• CMR Surgical Ltd. (Versius System)

• Johnson & Johnson MedTech (Ottava System)

• Stryker Corporation

• Olympus Corporation

• Karl Storz SE & Co. KG

• Richard Wolf GmbH

• Becton Dickinson and Company

• Avatera Medical GmbH

• Asensus Surgical Inc. (Intelligent Surgical Unit)

• Others

The Laparoscopic Robotic Assisted Prostatectomy Market is segmented as follows:

By Product Type

• Robotic Surgical Systems (Capital Equipment — da Vinci, Hugo, Versius, and Others)

• Laparoscopic Instruments & Accessories (Wristed Instruments, Trocars, Clip Appliers)

• Visualization Systems (3D HD Camera Systems, Fluorescence Imaging)

• Energy Devices (Monopolar, Bipolar, Ultrasonic)

• Other Product Types (Retractors, Sutures, Surgical Drapes)

By Procedure Type

• Radical Prostatectomy (Robotic Assisted Laparoscopic Radical Prostatectomy — RALP)

• Nerve-Sparing Prostatectomy (Unilateral and Bilateral Nerve-Sparing RALP)

• Extended Pelvic Lymph Node Dissection with Prostatectomy

• Simple Prostatectomy (for Benign Prostatic Hyperplasia)

• Other Procedure Types

By End-User

• Hospitals (Academic Medical Centers and Community Hospitals)

• Ambulatory Surgical Centers (ASCs)

• Specialty Urology Clinics

• Other End-Users

By Application

• Prostate Cancer (Localized and Locally Advanced)

• Benign Prostatic Hyperplasia (BPH)

• Other Applications

Regional Coverage:

North America

• U.S.

• Canada

• Mexico

• Rest of North America 

Europe

• Germany

• France

• U.K.

• Russia

• Italy

• Spain

• Netherlands

• Rest of Europe

Asia Pacific

• China

• Japan

• India

• New Zealand

• Australia

• South Korea

• Taiwan

• Rest of Asia Pacific 

The Middle East & Africa

• Saudi Arabia

• UAE

• Egypt

• Kuwait

• South Africa

• Rest of the Middle East & Africa

Latin America

• Brazil

• Argentina

• Rest of Latin America